17645621

Source:http://linkedlifedata.com/resource/pubmed/id/17645621

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0036043, umls-concept:C0039082, umls-concept:C0069805, umls-concept:C0087111, umls-concept:C0138666, umls-concept:C0878773, umls-concept:C1707455
pubmed:issue	7
pubmed:dateCreated	2007-7-24
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17645621-16834644
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9440237
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Benzilates, http://linkedlifedata.com/resource/pubmed/chemical/Mandelic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Parasympatholytics, http://linkedlifedata.com/resource/pubmed/chemical/oxybutynin, http://linkedlifedata.com/resource/pubmed/chemical/propiverine
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0919-8172
pubmed:author	pubmed-author:SchaeferWernerW
pubmed:issnType	Print
pubmed:volume	14
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	670; author reply 670-1
pubmed:meshHeading	pubmed-meshheading:17645621-Benzilates, pubmed-meshheading:17645621-Humans, pubmed-meshheading:17645621-Mandelic Acids, pubmed-meshheading:17645621-Parasympatholytics, pubmed-meshheading:17645621-Safety, pubmed-meshheading:17645621-Urinary Bladder, Overactive
pubmed:year	2007
pubmed:articleTitle	Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
pubmed:publicationType	Letter, Comparative Study, Comment